Zydus seeks DCGI nod for Pegylated Interferon alpha-2b to treat COVID-19
91.15 per cent of patients treated with PegIFN were RT PCR negative by day 7 as compared to 78.90 per cent on the standard of care…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.